How much debt does Fortress Biotech have?

Fortress Biotech had total debt of $74.30M as of Mar 31, 2026, against $79.38M in cash and short-term investments. Its debt-to-equity ratio was 1.49. Total debt was $75.96M a year earlier.

What are Fortress Biotech's total assets?

Fortress Biotech reported total assets of $185.55M as of Mar 31, 2026, up 28.7% from $144.22M a year earlier. Total liabilities were $123.36M.

What is Fortress Biotech's shareholders' equity?

Fortress Biotech's shareholders' equity was $49.87M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry.

Fortress Biotech (FBIO) Balance Sheet: Assets & Liabilities

Fortress Biotech Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Fortress Biotech, Inc. (FBIO) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Mar 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	79.38	79.38	57.26	57.26	80.93	178.27	305.74	233.35	233.35	136.86	65.51	113.92
Short-Term Investments	0.00	-	0.00	-	0.00	0.00	0.00	0.00	-	0.00	17.60	39.03
Cash & Short-Term Investments	79.38	79.38	57.26	57.26	80.93	178.27	305.74	233.35	233.35	136.86	83.11	130.95
Accounts Receivable	29.94	29.78	10.40	10.23	15.22	28.21	23.11	24.67	24.67	14.40	5.50	15.15
Inventory	9.62	9.62	14.43	14.43	10.21	14.16	9.86	1.40	1.40	0.86	0.68	0.17
Other Current Assets	5.05	4.90	8.28	8.28	10.50	9.66	7.07	6.72	6.72	4.13	21.92	44.30
Total Current Assets	123.84	123.84	90.37	90.37	117.02	230.43	346.46	266.15	266.15	156.25	111.21	183.18
Non-Current Assets
Property, Plant & Equipment (Net)	14.82	14.82	17.12	17.12	23.50	33.01	34.07	32.41	32.41	33.91	12.02	9.51
Long-Term Investments	17.66	17.66	1.55	2.59	2.44	2.69	2.22	19.21	17.57	11.15	0.00	1.39
Goodwill	0.00	-	0.00	-	0.00	0.00	0.00	0.00	-	0.00	0.00	18.65
Intangible Assets	27.61	27.61	31.86	31.86	20.29	27.20	12.55	14.63	14.63	7.38	1.42	15.22
Other Non-Current Assets	1.62	1.62	3.32	2.28	6.72	3.66	3.42	1.01	2.66	17.73	16.35	18.00
Total Non-Current Assets	61.71	61.71	53.85	53.85	50.50	63.87	50.04	67.26	-	70.17	29.79	62.77
Total Assets	185.55	185.55	144.22	144.22	167.53	294.30	396.50	333.41	333.41	226.42	140.99	245.95
Current Liabilities
Accounts Payable	14.24	47.13	31.64	65.50	34.81	97.45	90.66	11.41	11.41	10.05	17.86	10.00
Short-Term Debt	2.13	-	3.25	0.63	3.00	2.95	0.81	6.37	4.52	9.00	19.08	13.23
Current Portion of Long-Term Debt	-	-	-	0.63	3.93	2.05	4.51	-	4.52	-	-	-
Accrued Liabilities	-	28.91	-	30.74	32.66	36.51	39.99	-	31.26	-	-	-
Deferred Revenue	0.00	-	0.00	-	0.00	0.73	2.61	0.00	-	0.00	0.00	0.00
Other Current Liabilities	33.02	0.49	35.58	3.28	4.98	22.82	4.86	33.84	2.58	26.56	18.68	57.70
Total Current Liabilities	49.74	49.74	71.40	71.40	84.91	127.72	101.04	51.76	51.76	45.62	55.61	71.44
Non-Current Liabilities
Long-Term Debt	72.17	52.42	72.71	57.96	60.86	91.73	42.94	82.71	59.81	106.14	60.43	49.27
Other Non-Current Liabilities	1.45	8.53	1.76	1.76	1.89	3.26	5.66	1.95	1.95	2.14	5.21	4.74
Total Non-Current Liabilities	73.62	73.62	74.47	74.47	81.03	116.56	69.58	84.65	-	108.27	65.64	54.01
Total Liabilities	123.37	123.37	145.87	145.87	165.94	244.28	170.63	136.41	136.41	153.89	121.25	125.45
Stockholders' Equity
Common Stock	0.03	0.03	0.03	0.03	0.02	0.01	0.10	0.10	0.10	0.57	0.72	0.55
Retained Earnings	-734.05	-734.05	-740.87	-740.87	-694.87	-634.23	-547.46	-482.76	-482.76	-436.23	-396.27	-312.13
Additional Paid-in Capital	783.89	783.89	763.57	763.57	717.40	675.94	656.03	583.00	-	461.87	397.41	364.15
Minority Interest	12.31	12.31	-24.38	-24.38	-20.96	8.30	117.20	96.66	-	46.32	17.89	67.93
Shares Outstanding	-	31.36	-	27.91	15.09	7.37	6.76	-	-	-	-	-
Total Stockholders' Equity	49.87	62.18	22.74	-1.64	22.54	50.03	225.88	100.34	197.00	26.22	1.85	52.57
Total Liabilities & Equity	185.55	185.55	144.22	144.22	167.53	294.30	396.50	333.41	-	226.42	140.99	245.95

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Fortress Biotech Balance Sheet Analysis

Frequently Asked Questions About Fortress Biotech Balance Sheet